Performance
LowHasn't fared well - amongst the low performers
Valuation
AvgCan be considered moderately valued vs the market
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
—
—
—
Ind-Swift Limited is a manufacture of formulations. The Company is a pharmaceutical company, which offers finished goods dosage, active pharmaceutical ingredients (APIs) and herbal products.
Customise key metrics, see detailed forecasts, download stock data and more
A significant proportion of promoter holdings is pledged
In last 3 months, mutual fund holding of the company has almost stayed constant
Ind-Swift Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2024. Further, the company has informed the Exchange regarding voting results. | Download
Ind-Swift Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2024. Further, the company has informed the Exchange regarding voting results. | Download
Ind-Swift Limited has informed the Exchange about Disclosure under Regulation 30 of Securities Exchange Board of India (Listing Obligations and Disclosures Requirements), Regulations, 2015 ( Listing Regulation ) | Download
Ind-Swift Limited has informed the Exchange about Disclosure under Regulation 30 of Securities Exchange Board of India (Listing Obligations and Disclosures Requirements), Regulations, 2015 ( Listing Regulation ) | Download
Final • Div/Share: ₹ 0.4
Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has almost stayed constant